Meet Our Employees
Meet Cathy Anderson
Dr. Anderson has more than 12 years of professional experience managing long-term research projects. As a scientist at Cato Research, Dr. Anderson is responsible for developing regulatory strategy for products from the preclinical through the postmarketing stage. She is also responsible for critical activities such as project management, writing and reviewing regulatory, clinical, and scientific documents, and regulatory and scientific consulting. Before joining Cato Research, Dr. Anderson’s work focused on signaling, metabolism, and gene/protein regulation. Her graduate work in microbiology examined the mechanisms and effects of metabolic regulation, and she continued to investigate the global effects of signaling and metabolism during her postdoctoral work at Duke University. As a scientist at a large biotechnology company, Dr. Anderson identified and characterized advantageous mutations for patent submissions. Since joining Cato Research, she has provided strategic regulatory and clinical planning and implementation for drug and biologic products in areas such as oncology, dermatology, and antimicrobials.
Dr. Anderson has more than 12 years of professional experience managing long-term research projects. As a
scientist at Cato Research, Dr. Anderson is responsible for developing regulatory strategy for products from
the preclinical through the postmarketing stage. She is also responsible for critical activities such as project
management, writing and reviewing regulatory, clinical, and scientific documents, and regulatory and
scientific consulting. Before joining Cato Research, Dr. Anderson’s work focused on signaling, metabolism,
and gene/protein regulation. Her graduate work in microbiology examined the mechanisms and effects of
metabolic regulation, and she continued to investigate the global effects of signaling and metabolism during
her postdoctoral work at Duke University. As a scientist at a large biotechnology company, Dr. Anderson
identified and characterized advantageous mutations for patent submissions. Since joining Cato Research, she
has provided strategic regulatory and clinical planning and implementation for drug and biologic products in
areas such as oncology, dermatology, and antimicrobials.